Status
Conditions
Treatments
About
.The goal of this interventional study is to estimate the diagnostic performance of plasma biomarkers of interest (Aβ40 and Aβ42, P-Tau and NFL), enabling discrimination between patients with and without a pathophysiological AD process. The main questions it aims to answer are:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
189 participants in 1 patient group
Loading...
Central trial contact
catherine Malaplate, PhD,PharmD; Thérèse Jonveaux, PhD, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal